Diaceutics PLC
LSE: DXRX.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Ryan Keeling
- Employees
- 184
- Headquarters
- Belfast, United Kingdom
- IPO year
- 2019
- Market cap
- £149.3M
- Website
- https://www.diaceutics.com
Loading DXRX…
Loading profile data…Frequently asked questions about DXRX
What does Diaceutics PLC (DXRX.L) do?
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapp...
Where does DXRX.L trade?
Diaceutics PLC (DXRX.L) trades on the London Stock Exchange.
What sector is DXRX.L in?
Diaceutics PLC (DXRX.L) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Diaceutics PLC?
Ryan Keeling is the chief executive officer of Diaceutics PLC (DXRX.L).
Where is Diaceutics PLC headquartered?
Diaceutics PLC is headquartered in United Kingdom.
Does DXRX.L pay a dividend?
Diaceutics PLC (DXRX.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did DXRX.L go public?
Diaceutics PLC (DXRX.L) completed its initial public offering in 2019.